Package 69097-531-53

{"route": ["ORAL"], "spl_id": "176f3856-e33d-4fb2-9fe9-72d96c5eabe8", "openfda": {"unii": ["6871619Q5X"], "rxcui": ["763306"], "spl_set_id": ["195e06db-b76c-4470-b6a5-a3979c25046d"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 PACKET in 1 CARTON (69097-531-53)  / 1 SUSPENSION in 1 PACKET (69097-531-31)", "package_ndc": "69097-531-53", "marketing_start_date": "20250403"}], "brand_name": "PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release", "product_id": "69097-531_176f3856-e33d-4fb2-9fe9-72d96c5eabe8", "dosage_form": "SUSPENSION", "pharm_class": ["Proton Pump Inhibitor [EPC]", "Proton Pump Inhibitors [MoA]"], "product_ndc": "69097-531", "generic_name": "pantoprazole sodium granules", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PANTOPRAZOLE SODIUM DELAYED-RELEASE", "brand_name_suffix": "delayed release", "active_ingredients": [{"name": "PANTOPRAZOLE SODIUM", "strength": "40 mg/1"}], "application_number": "ANDA217458", "marketing_category": "ANDA", "marketing_start_date": "20250403", "listing_expiration_date": "20261231"}